Specialty Pharmacy’s Impact on RA Therapy Adherence
Nonadherence is a major concern for patients with rheumatoid arthritis (RA) receiving biological disease-modifying agents. The medication possession ratio, which is a measurement of the time that patients have access to medications, ranges from 0.44 to 0.83 in this patient population. The question remains: Can medication adherence be improved in patients with RA, which may improve long-term outcomes? Read more.

Polymorphism Linked to Survival in Non-Small Cell Lung Cancer
Non-small cell lung cancer (NSCLC) accounts for 85% of all lung cancers. In recent years, innovative therapeutic modalities targeting epidermal growth factor receptor-mutant and anaplastic lymphoma kinase-rearranged variants of NSCLC have revolutionized care. However, for patients without these biomarkers, there has been little assistance in guiding therapy. Read more.

Managing Breast Cancer During Pregnancy
Pregnancy-associated breast cancer is breast cancer (BC) diagnosed during pregnancy, in the first postpartum year, or at any time during lactation. It occurs in 15 to 35 per 100,000 deliveries in the United States or one per 1,000 pregnancies yearly. Given the risk to both mother and child, is it possible to personalize the diagnosis and treatment of BC during pregnancy? Read more.